SHANE GAGON: Open Payments
NPI 1508951328 · PRICE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 78 payments from 25 companies in 2025. Trend: 2023 $841 · 2024 $781 · 2025 $1,348
Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $258 |
| AstraZeneca Pharmaceuticals LP | 14 | $247 |
| PFIZER INC. | 16 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| Supernus Pharmaceuticals, Inc. | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Globus Medical, Inc. | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| PROTEGA PHARMACEUTIALS INC | 2 | $30 |
Products named: VRAYLAR, NURTEC ODT, BREZTRI, Kerendia, Qelbree, AIRSUPRA, UBRELVY, JARDIANCE.
Industry payments across UT — which companies pay providers there.
